|
SLC38A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.06249997478392E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.14400000051607E-07 |
| Normal-vs-Stage2 |
6.280100E-03 |
| Normal-vs-Stage3 |
5.696400E-03 |
| Normal-vs-Stage4 |
8.642200E-02 |
| Stage1-vs-Stage2 |
4.530800E-01 |
| Stage1-vs-Stage3 |
6.078800E-01 |
| Stage1-vs-Stage4 |
5.480600E-01 |
| Stage2-vs-Stage3 |
8.405600E-01 |
| Stage2-vs-Stage4 |
8.065800E-01 |
| Stage3-vs-Stage4 |
6.904800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05460000013424E-07 |
| Normal-vs-AfricanAmerican |
3.94449999996382E-06 |
| Normal-vs-Asian |
2.642200E-01 |
| Caucasian-vs-AfricanAmerican |
2.208800E-01 |
| Caucasian-vs-Asian |
8.013200E-01 |
| AfricanAmerican-vs-Asian |
8.718800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87599999978971E-07 |
| Normal-vs-Female |
3.39800000026536E-07 |
| Male-vs-Female |
4.005800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.344300E-03 |
| Normal-vs-Extreme_Weight |
5.602000E-04 |
| Normal-vs-Obese |
1.3519999999545E-06 |
| Normal-vs-Extreme_Obese |
1.350430E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.555800E-01 |
| Normal_Weight-vs-Obese |
4.405400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.696800E-01 |
| Extreme_Weight-vs-Obese |
5.144200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.756600E-01 |
| Obese-vs-Extreme_Obese |
5.081400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.018580E-03 |
| Normal-vs-Age(41-60Yrs) |
2.012099997728E-08 |
| Normal-vs-Age(61-80Yrs) |
1.5023399999925E-05 |
| Normal-vs-Age(81-100Yrs) |
4.591000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.325800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.241300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.758200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.502170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.244900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.772000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.83580000090444E-08 |
| Normal-VS-Type2 PRCC |
8.884700E-03 |
| Normal-VS-KIRP CIMP |
1.599890E-03 |
| Normal-VS-Unclassified PRCC |
9.002900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.487900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.199970E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.043800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.655900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.072000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.697900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.721700E-02 |
| Normal-vs-N1 |
4.018100E-03 |
| Normal-vs-N2 |
2.283800E-01 |
| N0-vs-N1 |
6.696100E-02 |
| N0-vs-N2 |
3.162800E-01 |
| N1-vs-N2 |
3.678000E-01 |
|
|
